Fig. 1From: A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patientsFlowchart of the selection strategy and inclusion/exclusion criteria in the current meta-analysis. EES: everolimus-eluting stents, ZES: zotarolimus-eluting stents, PES: paclitaxel-eluting stents, SES: sirolimus-eluting stentsBack to article page